Skip to main content
. 2019 Nov 28;47(3):713–720. doi: 10.1007/s00259-019-04584-1

Fig. 3.

Fig. 3

Kaplan-Meier survival plot of the patients stratified by PSA response. In comparison to patients with no PSA decline, patients with any PSA reduction up to 50% and more lived significantly longer (median survival not reached vs. 52 weeks, P < 0.0001)